Skip to main content

Table 3 Survivin, XIAP and XAF1 immunoreactivity.

From: Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma

  

Survivin

XIAP

XAF1

 

IHC score*

n

(%)

n

(%)

n

(%)

HCC

Negative

-

 

7

17,5%

23

57,5%

 

Low

22

55,0%

23

57,5%

17

42,5%

 

High

18

45,0%

10

25,0%

-

 

Adjacent liver#

Negative

-

 

10

25,0%

21

52,5%

 

Low

2

5,0%

19

47,5%

19

47,5%

 

High

38

95,0%

11

27,5%

-

 

Non-adjacent liver#

Negative

-

 

12

30,0%

25

62,5%

 

Low

1

2,5%

18

45,0%

15

37,5%

 

High

39

97,5%

10

25,0%

-

 
  1. The number (n) and the percentage of patients (%) in each IHC category are indicated.
  2. *Negative (score 0), Low (score 1–6) and High (score 7–12).
  3. #Adjacent liver: liver parenchyma at less than 1 cm from the tumor; non-adjacent liver: liver parenchyma at more than 3 cm from tumor.